Bio Decontamination - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Bio Decontamination - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

The bio-decontamination market is projected to register a CAGR of 6.2% during the forecast period.

As the impact of the COVID-19 outbreak widened and the number of patients admitted to hospitals grew, medical professionals and hospital administrators were looking for emergency alternatives that provided more beds for patients during the crisis by leveraging empty facilities, re-purposing space within an existing hospital, or building temporary structures to serve as hospitals. Hospital-acquired COVID-19 infections represent a serious public health issue, which is a problem that makes patients reluctant to seek hospital treatment for fear of becoming infected. As per the article published by NCBI in January 2021, despite numerous measures to contain the infection and limit its spread, cases of SARS-CoV-2 infections acquired in hospitals have been reported consistently during the pandemic. As per the same source, the SARS-CoV-2 hospital-acquired infection rate was 12-15% globally during the pandemic. Hence, due to the COVID-19 pandemic, the necessity to use sterilization has increased.

The increasing numbers of hospital-acquired COVID-19 infections and other secondary infections in the patients caused a surge in demand for bio-decontamination equipment and consumables to curb the spread of the disease and manage the conditionsrose in the affected patients. A study published in the Journal Lancet in September 2021 highlighted the increase in hospital-acquired infections (HAIs) in patients admitted to the hospital in the United Kingdom. It was found that over 11.3% of patients with COVID-19 in 314 United Kingdom hospitals got infections after hospital admission, and it increased to 15.8% during the pandemic. It was also observed that 6.8% of all patients with COVID-19 acquired nosocomial infections, and it increased to 8.2% of patients having nosocomial conditions during the pandemic. Thus, the COVID-19 outbreak has positively impacted the market's growth in its preliminary phase. Moreover, the market is expected to grow at a stable pace with the increasing cases of HAIs, which would drive the growth of bio-decontamination equipment and consumables globally.

The major factors driving the growth of the bio-decontamination market are the rising incidence of hospital-acquired infections (HAIs), the increasing number of surgical procedures, and the increasing outsourcing of bio-decontamination services.

The rising number of surgical wound infections, post-surgery infections, is predicted to drive the demand for bio-decontamination equipment and services to curb the infection rate. The number of surgeries is increasing, driven by the high burden of chronic diseases, cesarean birth procedures, trauma cases, etc. The chronic conditions of cardiovascular diseases, cancer, and others lead to many surgical interventions. In the recent few years, there has been an increase in the volume of heart surgery, mastectomies (breast removal surgery to control breast cancer), and cesarean birth procedures, which are highly associated with post-surgery infections at hospitals. According to the data updated by the OECD in April 2023, over 50,597 and 3,619 procedures of complete mastectomies were performed in Turkey and Portugal, respectively, in 2021. The surgical procedure for mastectomy is also associated with a high risk of post-surgery infections. For instance, a study published in the Journal of Plastic, Reconstructive & Aesthetic Surgery in January 2022 highlighted the risk of HAIs associated the breast removal surgeries or mastectomy as the patient stays in the hospital. The study stated thextendedhe long stay at the hospital after the mastectomy and increased length of surgical drain retention are likely to cause infections in older female patients.

Furthermore, cesarean birth procedures are also carried out in large numbers that are highly prone to HAIs. OECD in April 2023 stated that over 82,532 and 21,268 cesarean sections were performed in Chile and Ireland, respectively, in 2021. A study published in the Journal PLoS One in June 2021 highlighted the high prevalence of post-Cesarean section (CS) surgical site infection in hospitals (SSI). The study stated that CS-SSI majorityalence of 12.3%. The study underlined that the general anesthesia and hospital stays even over seven days after the CS contributed significantly towards the CS-SSI. Thus, the high volume of surgical procedures and the high risk of postoperative infections are expected to create more demand for bio-decontamination equipment and consumables.

Thus, all the aforementioned factors are expected to drive market growth over the forecast period. However, limitations in reallocating resources and adjusting budgets in health care may hamper the usefulness of economic evaluation for decision-making as limited resources would hinder the adoption rate of bio-decontamination devices and services. Thus, budgetary constraints in healthcare facilities are expected to hamper market growth.

Bio Decontamination Market Trends

Hydrogen Peroxide Segment is Expected to Hold a Significant Growth Rate Over the Forecast Period

Bio-decontamination agents such as hydrogen peroxide can be used in the hospital and other healthcare to clean the facilities and decontaminate them from infectious microorganisms. Hydrogen peroxide is a commonly used decontaminant in hospitals. It helps reduce the spread of hospital-acquired infections such as ventilator-associated pneumonia, hospital-acquired pneumonia, and Clostridium difficile infections.

According to an article published by NCBI in March 2022, hydrogen peroxide-based decontamination technologies are widespread. It demonstrated an efficacy equal to that of traditionally employed methods when paired with advancements in their delivery systems. The use of hydrogen peroxide de-contamination systems in laboratories has been studied and compared. It demonstrated the efficacy of high-concentration hydrogen peroxide in decontamination using various delivery devices. The decontamination instrument, paired with the pulsed 7% hydrogen peroxide solution, achieved efficacy regardless of variables in laboratory size and layout.

In addition, according to an article published by Elsevier in February 2022, companies such as STERIS Sterilization Systems and Advanced Sterilization Products received authorization from the United States Food and Drug Administration for vaporized and hydrogen peroxide gas plasma decontamination systems used in the decontamination process of N95 respirators. According to the same source, a study showed that vaporous hydrogen peroxide and moist heat have the most promise as potential methods to decontaminate N95 respirators. Moreover, hydrogen peroxide gas plasma (HPGP) and aerosolized hydrogen peroxide have also been suggested as possible techniques for decontamination in personal protective equipment. Hence, due to the increasing use of hydrogen peroxide in the bio-decontamination process, the studied segment is expected to experience growth.

In September 2021, Steris launched the next generation of their vaporized hydrogen peroxide (VHP) bio-decontamination systems to achieve 6-log bioburden reduction in good-manufacturing-practice pharmaceutical, medical device, and research facilities. The new decontamination systems can be integrated into a facility's building automation, and a decontamination cycle can be run at programmed intervals or with the push of a button. Similarly, in December 2021, TOMI Environmental Solutions, Inc., a global company specializing in disinfection and decontamination, launched the SteraMist Amazon Store, including the SteraPak and Binary Ionization Technology (BIT). The SteraPak utilizes our SteraMist ionized Hydrogen Peroxide (iHP) disinfection technology, offering a powerful disinfectant that is quick, non-corrosive, and easy to use due to no need for mixing, wiping, or rinsing.

Hence, due to several applications associated with the hydrogen peroxide reagent, and an increasing number of product development, the segment is expected to register significant growth during the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

The geographical analysis of the Bio Decontamination Market shows that North America holds a major market share in the global market. This is due to the robust growth of the healthcare sector in North America, increasing incidences of hospital-acquired infections in the region, the growing geriatric population, greater government initiatives, and investments toward hygiene in healthcare facilities.

As per the data published by the United States Department of Health & Human Services in November 2022, 30,389 catheter line-associated bloodstream infections were recorded in acute care hospitals in the United States, in 2021. As per the same source, over 1,995 cases of ventilator-associated infections were reported by acute care hospitals in the United States in 2021.

Furthermore, the region has a high volume of surgeries which also increases the risk of contracting HAIs, increasing the demand for hospital infection therapeutics in the region. For instance, data published by the Canadian Institute for Health Information (CIHI) in June 2022, over 110,000 procedures of joint replacements were performed in 2020-2021, and more than 7,300 procedures were performed as day surgeries in Canada.

Thus, with the increasing prevalence of various hospital-acquired infections in the country, the United States region is a highly attractive and stable region for the growth of companies and consumers in the bio-decontamination market.

Bio Decontamination Industry Overview

The market players are implementing various strategies such as partnerships, expansion, and new product launches to sustain their position in the market. The market is partially fragmented and consists of several major players. Some companies currently dominating the market are Steris PLC, Ecolab, Tomi Environmental Solutions Inc., JCE Biotechnology, and Zhejiang Tailin Bioengineering Co. Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support